Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nomograms to predict late urinary toxicity after prostate cancer radiotherapy.
Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, Bossi A, Le Prisé E, Guerif S, Simon JM, Dubray B, Zhu J, Lagrange JL, Pommier P, Gnep K, Acosta O, De Crevoisier R. Mathieu R, et al. Among authors: beckendorf v. World J Urol. 2014 Jun;32(3):743-51. doi: 10.1007/s00345-013-1146-8. Epub 2013 Aug 29. World J Urol. 2014. PMID: 23990073 Free article.
Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results.
Bey P, Carrie C, Beckendorf V, Ginestet C, Aletti P, Madelis G, Luporsi E, Pommier P, Cowen D, Gonzague-Casabianca L, Simonian-Sauve M, Maingon P, Naudy S, Lagrange J, Marcie S. Bey P, et al. Among authors: beckendorf v. Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):513-7. doi: 10.1016/s0360-3016(00)00691-x. Int J Radiat Oncol Biol Phys. 2000. PMID: 10974470
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity.
Beckendorf V, Guérif S, Le Prisé E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P. Beckendorf V, et al. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1056-65. doi: 10.1016/j.ijrobp.2004.05.033. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519775 Clinical Trial.
[Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
Marchal C, Lapeyre M, Beckendorf V, Aletti P, Haslé E, Dubois JB, Maingon P, Bensadoun RJ, Le Prise E, Lartigau E, Carrie C, Dubray B, Marchesi V, Ailleres N, Naudy S, Marcie S, Manens JP, Mazurier J, Ginestet C, Chauvin F, Pommier P, Gerard JP, Carrere MO. Marchal C, et al. Among authors: beckendorf v. Cancer Radiother. 2004 Nov;8 Suppl 1:S121-7. Cancer Radiother. 2004. PMID: 15679257 French.
Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.
Pommier P, Chabaud S, Lagrange JL, Richaud P, Lesaunier F, Le Prise E, Wagner JP, Hay MH, Beckendorf V, Suchaud JP, Pabot du Chatelard PM, Bernier V, Voirin N, Perol D, Carrie C. Pommier P, et al. Among authors: beckendorf v. J Clin Oncol. 2007 Dec 1;25(34):5366-73. doi: 10.1200/JCO.2006.10.5171. J Clin Oncol. 2007. PMID: 18048817 Clinical Trial.
Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015).
Lagrange JL, Bascoul-Mollevi C, Geoffrois L, Beckendorf V, Ferrero JM, Joly F, Allouache N, Bachaud JM, Chevreau C, Kramar A, Chauvet B; Study Group on Genito-Urinary Tumors. Lagrange JL, et al. Among authors: beckendorf v. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):172-8. doi: 10.1016/j.ijrobp.2009.10.038. Epub 2010 Apr 10. Int J Radiat Oncol Biol Phys. 2011. PMID: 20385453 Clinical Trial.
58 results